Most Read Articles
6 days ago
Regardless of birth weight, being obese at preschool age is associated with a greater risk of elevated blood pressure during early childhood, a recent China study has found. A longer duration of breastfeeding appears to help mitigate such a risk.
Jairia Dela Cruz, 3 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
06 Sep 2020
Type 2 diabetes mellitus patients taking proton pump inhibitors (PPIs) are at a higher risk of sustaining hip fractures, a recent study has found.
5 days ago
Osteoarthritis (OA) is the most common condition affecting the joints. Dr Lee Eu Jin, an Orthopaedic Surgeon from Liberty Orthopaedic Clinic at Mount Elizabeth Medical Centre, Singapore, shares his insights with Pearl Toh on how to manage OA in the primary care setting.


Diagnostic delay in PAH persists, linked to lower survival

09 Aug 2020

Despite increased community awareness, diagnostic delays persist among patients with pulmonary arterial hypertension (PAH), claims a recent study, noting that those who experience longer diagnostic interval are at higher risk of mortality.

Moreover, age, cardiovascular and respiratory comorbidities are significantly associated with longer time to diagnosis.

To assess the magnitude, risk factors, and survival impact of diagnostic delay in Australian and New Zealand, the authors performed a cohort study of PAH patients from the PHSANZ Registry diagnosed from 2004 to 2017.

Diagnostic interval referred to the time from symptom onset to diagnostic right heart catheterization as recorded in the registry. A multivariate logistic regression model was generated to analyse the factors associated with diagnostic delay. Kaplan–Meier method and Cox regression were used to compare survival rates across patients based on the time to diagnosis.

A total of 2,044 PAH patients were eligible for the analysis. Median age at diagnosis was 58 years (interquartile range [IQR], 43–69 years); female-to-male ratio was 2.8:1, and majority of the patients (82 percent) were classified as having New York Heart Association functional classification III–IV.

The median diagnostic interval was 1.2 years (IQR, 0.6–2.7 years). A diagnostic interval of ≥1 year was independently predicted by the following factors: age, congenital heart disease-PAH, obstructive sleep apnoea, and peripheral vascular disease.

There has been no improvement in diagnostic interval during the study period. Furthermore, an association was found between longer diagnostic delay and reduced 5-year survival.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Regardless of birth weight, being obese at preschool age is associated with a greater risk of elevated blood pressure during early childhood, a recent China study has found. A longer duration of breastfeeding appears to help mitigate such a risk.
Jairia Dela Cruz, 3 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
06 Sep 2020
Type 2 diabetes mellitus patients taking proton pump inhibitors (PPIs) are at a higher risk of sustaining hip fractures, a recent study has found.
5 days ago
Osteoarthritis (OA) is the most common condition affecting the joints. Dr Lee Eu Jin, an Orthopaedic Surgeon from Liberty Orthopaedic Clinic at Mount Elizabeth Medical Centre, Singapore, shares his insights with Pearl Toh on how to manage OA in the primary care setting.